Press Releases - 2025
FOR IMMEDIATE RELEASE
GLOBAL CANCER ORGANIZATION APPLAUDS SURGEON GENERAL'S ADVISORY ON ALCOHOL AND CANCER RISK
January 9, 2025
GLOBAL CANCER ORGANIZATION APPLAUDS SURGEON GENERAL'S ADVISORY ON ALCOHOL AND CANCER RISK
January 9, 2025
CAMBRIDGE, MASSACHUSETTS, USA – January 9, 2025 – Cancer Education and Research Institute® (CERI), a leading global cancer organization, the recipient of a United Nations award, welcomes the U.S. Surgeon General’s recent advisory on the link between alcohol consumption and cancer risk. This long-overdue step aligns with the scientific evidence that CERI has been compiling, analyzing, reporting on, and educating the public and patients about for over a decade.
"Finally!" said Dr. Ayguen Sahin, MSc, PhD, a cancer scientist with 25 years of experience and the founder and CEO of CERI. "The Surgeon General's advisory validates what our organization has long emphasized - that alcohol is a significant, yet preventable, cause of cancer.”
"Finally!" said Dr. Ayguen Sahin, MSc, PhD, a cancer scientist with 25 years of experience and the founder and CEO of CERI. "The Surgeon General's advisory validates what our organization has long emphasized - that alcohol is a significant, yet preventable, cause of cancer.”
Cancer Education and Research Institute's CEO, founder, and cancer lead, Dr. Ayguen Sahin, reacts to U.S. Attorney General's advisory on alcohol and cancer risk on the platform X.
The advisory, released on January 3, 2025, by U.S. Surgeon General Dr. Vivek Murthy, highlights alcohol as the third leading preventable cause of cancer in the United States, following tobacco and obesity. It underscores the need for increased public awareness and recommends updating warning labels on alcoholic beverages to include cancer risk information.
"For years, we've been at the forefront of educating the public about the alcohol-cancer link," Dr. Sahin continued. "Our decade-long efforts and uniquely designed education, awareness, and patient programs have proven to be effective for the public and patients alike, but there's still work to be done. This advisory will significantly boost our ongoing mission to raise awareness and reduce alcohol-related cancer risks."
While commending the government's progress in addressing tobacco and alcohol risks, Dr. Sahin also called for similar attention to other potential health concerns. "As we make strides in tobacco and alcohol awareness, we must also address the increasing marketing and use of marijuana products, particularly among young adults. The public needs clear, science-based guidance on all substances that may impact their health."
CERI remains committed to its mission of providing worldwide access to high-quality cancer care, research, and education. This advisory aligns perfectly with our ongoing efforts to disseminate crucial information about cancer prevention and risk factors. We stand ready to collaborate with health authorities, policymakers, and the public to further reduce the burden of alcohol-related cancers.
For more information about alcohol and cancer risk, please visit canceredinstitute.org/alcohol-and-cancer.
###
"For years, we've been at the forefront of educating the public about the alcohol-cancer link," Dr. Sahin continued. "Our decade-long efforts and uniquely designed education, awareness, and patient programs have proven to be effective for the public and patients alike, but there's still work to be done. This advisory will significantly boost our ongoing mission to raise awareness and reduce alcohol-related cancer risks."
While commending the government's progress in addressing tobacco and alcohol risks, Dr. Sahin also called for similar attention to other potential health concerns. "As we make strides in tobacco and alcohol awareness, we must also address the increasing marketing and use of marijuana products, particularly among young adults. The public needs clear, science-based guidance on all substances that may impact their health."
CERI remains committed to its mission of providing worldwide access to high-quality cancer care, research, and education. This advisory aligns perfectly with our ongoing efforts to disseminate crucial information about cancer prevention and risk factors. We stand ready to collaborate with health authorities, policymakers, and the public to further reduce the burden of alcohol-related cancers.
For more information about alcohol and cancer risk, please visit canceredinstitute.org/alcohol-and-cancer.
###
About CERI Personalized Patient Program™:
Through the CERI Personalized Patient Program™ (canceredinstitute.org/patient-program), Cancer Education and Research Institute® acts as a liaison between cancer patients and medical professionals. It bridges the gap between cancer specialists and cancer patients, and provides patients and their families personalized, simplified education in local language about the cancer type being dealt with, including targeted treatment and latest research. It further identifies, and guides patients toward clinical trials and top specialists in their disease. This allows timely and efficient treatment.
About Cancer Education and Research Institute®:
Cancer Education and Research Institute® (canceredinstitute.org), is an award-winning, independent, Boston-based, 501(c)(3) global non-profit organization. Its mission is to 1) make cancer and cancer research understandable for everyone; 2) bridge the gap between cancer professionals and cancer patients; 3) provide cancer research scholarships for promising high school students worldwide, career guidance, and mentorship; and 4) conduct in-house innovative cancer research and directly translate it to the public. Cancer Education and Research Institute® is the United Nations, UNIATF Award 2019 recipient.
Through the CERI Personalized Patient Program™ (canceredinstitute.org/patient-program), Cancer Education and Research Institute® acts as a liaison between cancer patients and medical professionals. It bridges the gap between cancer specialists and cancer patients, and provides patients and their families personalized, simplified education in local language about the cancer type being dealt with, including targeted treatment and latest research. It further identifies, and guides patients toward clinical trials and top specialists in their disease. This allows timely and efficient treatment.
About Cancer Education and Research Institute®:
Cancer Education and Research Institute® (canceredinstitute.org), is an award-winning, independent, Boston-based, 501(c)(3) global non-profit organization. Its mission is to 1) make cancer and cancer research understandable for everyone; 2) bridge the gap between cancer professionals and cancer patients; 3) provide cancer research scholarships for promising high school students worldwide, career guidance, and mentorship; and 4) conduct in-house innovative cancer research and directly translate it to the public. Cancer Education and Research Institute® is the United Nations, UNIATF Award 2019 recipient.
Media Inquiries
Reporters may contact
Ayguen Sahin, M.Sc., Ph.D.
CEO, Founder, and Cancer Lead
Cancer Education and Research Institute (CERI)
for more information, or to schedule interviews.
Contact
Reporters may contact
Ayguen Sahin, M.Sc., Ph.D.
CEO, Founder, and Cancer Lead
Cancer Education and Research Institute (CERI)
for more information, or to schedule interviews.
Contact
#cancer #health #cancertreatment #cancerpatient #cancerprevention #cancereducation
Media Resources
CERI Media Kit - 2025
Download the CERI Media Kit 2025
| ceri_media_kit_2025.pdf |
CERI Media Kit 2022
| ceri_media_kit.pdf |
Annual Reports and Media Kit (2013-2018)
Cancer Education and Research Institute (CERI)®'s Annual Reports and Media Kit include our 5-year (2013-2018) progress and achievements, fact sheets and demographics, information about our programs, and sponsorship opportunities.
To read our Annual Reports and Media Kit click here.
To read our Annual Reports and Media Kit click here.
